These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 20638740)

  • 1. Down-regulation of survivin by oxaliplatin diminishes radioresistance of head and neck squamous carcinoma cells.
    Khan Z; Khan N; Tiwari RP; Patro IK; Prasad GB; Bisen PS
    Radiother Oncol; 2010 Aug; 96(2):267-73. PubMed ID: 20638740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cells.
    Fujie Y; Yamamoto H; Ngan CY; Takagi A; Hayashi T; Suzuki R; Ezumi K; Takemasa I; Ikeda M; Sekimoto M; Matsuura N; Monden M
    Jpn J Clin Oncol; 2005 Aug; 35(8):453-63. PubMed ID: 16024531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic trioxide induced the apoptosis of laryngeal cancer via down-regulation of survivin mRNA.
    Cheng B; Yang X; Han Z; An L; Liu S
    Auris Nasus Larynx; 2008 Mar; 35(1):95-101. PubMed ID: 17869043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survivin is a downstream target and effector of sulindac-sensitive oncogenic Stat3 signalling in head and neck cancer.
    Scheper MA; Nikitakis NG; Sauk JJ
    Int J Oral Maxillofac Surg; 2007 Jul; 36(7):632-9. PubMed ID: 17566705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxaliplatin-mediated inhibition of survivin increases sensitivity of head and neck squamous cell carcinoma cell lines to paclitaxel.
    Khan Z; Khan N; Varma AK; Tiwari RP; Mouhamad S; Prasad GB; Bisen P
    Curr Cancer Drug Targets; 2010 Nov; 10(7):660-9. PubMed ID: 20578991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of Cisplatin sensitivity in squamous cell carcinoma of the head and neck transfected with a survivin antisense gene.
    Kojima H; Iida M; Yaguchi Y; Suzuki R; Hayashi N; Moriyama H; Manome Y
    Arch Otolaryngol Head Neck Surg; 2006 Jun; 132(6):682-5. PubMed ID: 16785416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined evaluation of expression of telomerase, survivin, and anti-apoptotic Bcl-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers.
    Sharma H; Sen S; Mathur M; Bahadur S; Singh N
    Head Neck; 2004 Aug; 26(8):733-40. PubMed ID: 15287041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of cyclooxygenase-2 inhibitors and oxaliplatin increases the growth inhibition and death in human colon cancer cells.
    Lin J; Hsiao PW; Chiu TH; Chao JI
    Biochem Pharmacol; 2005 Sep; 70(5):658-67. PubMed ID: 16004971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma.
    Katayama A; Ogino T; Bandoh N; Nonaka S; Harabuchi Y
    Clin Cancer Res; 2005 Apr; 11(8):2937-46. PubMed ID: 15837745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prodigiosin down-regulates survivin to facilitate paclitaxel sensitization in human breast carcinoma cell lines.
    Ho TF; Peng YT; Chuang SM; Lin SC; Feng BL; Lu CH; Yu WJ; Chang JS; Chang CC
    Toxicol Appl Pharmacol; 2009 Mar; 235(2):253-60. PubMed ID: 19133282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxaliplatin induces apoptosis in hepatocellular carcinoma cells and inhibits tumor growth.
    Wang Z; Zhou J; Fan J; Qiu SJ; Yu Y; Huang XW; Sun J; Tan CJ; Dai Z
    Expert Opin Investig Drugs; 2009 Nov; 18(11):1595-604. PubMed ID: 19780708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genistein induced molecular changes in a squamous cell carcinoma of the head and neck cell line.
    Alhasan SA; Ensley JF; Sarkar FH
    Int J Oncol; 2000 Feb; 16(2):333-8. PubMed ID: 10639578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Number of negative points: a novel method for predicting radiosensitivity in head and neck tumor cell lines.
    Farnebo L; Jerhammar F; Vainikka L; Grénman R; Norberg-Spaak L; Roberg K
    Oncol Rep; 2008 Aug; 20(2):453-61. PubMed ID: 18636211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and Akt signaling.
    Watson JL; Greenshields A; Hill R; Hilchie A; Lee PW; Giacomantonio CA; Hoskin DW
    Mol Carcinog; 2010 Jan; 49(1):13-24. PubMed ID: 19676105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of survivin by siRNA diminishes radioresistance of pancreatic cancer cells.
    Kami K; Doi R; Koizumi M; Toyoda E; Mori T; Ito D; Kawaguchi Y; Fujimoto K; Wada M; Miyatake S; Imamura M
    Surgery; 2005 Aug; 138(2):299-305. PubMed ID: 16153440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COX-independent antineoplastic effects of sulindac in oral cancer are mediated by survivin down-regulation.
    Scheper MA; Sauk JJ; Nikitakis NG
    Anticancer Res; 2006; 26(6B):4103-13. PubMed ID: 17201121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.
    Rahman KW; Li Y; Wang Z; Sarkar SH; Sarkar FH
    Cancer Res; 2006 May; 66(9):4952-60. PubMed ID: 16651453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. siRNA targeting survivin inhibits growth and induces apoptosis in human renal clear cell carcinoma 786-O cells.
    Zhang Y; Chen ZD; Du CJ; Xu G; Luo W
    Pathol Res Pract; 2009; 205(12):823-7. PubMed ID: 19628339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effects of Nafamostat mesilate on head and neck squamous cell carcinoma.
    Yamashita Y; Ishiguro Y; Sano D; Kimura M; Fujita K; Yoshida T; Horiuchi C; Taguchi T; Matsuda H; Mikami Y; Tsukuda M
    Auris Nasus Larynx; 2007 Dec; 34(4):487-91. PubMed ID: 17337140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumor activity of heptaplatin in combination with 5-fluorouracil or paclitaxel against human head and neck cancer cells in vitro.
    Lee JW; Park JK; Lee SH; Kim SY; Cho YB; Kuh HJ
    Anticancer Drugs; 2006 Apr; 17(4):377-84. PubMed ID: 16549994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.